|Dr. Hwei Pink Wong||CEO & Exec. Director||N/A||N/A||N/A|
|Mr. Yuyun Shen||Exec. Director||N/A||N/A||N/A|
|Ms. Beng Hong Ong L.L.B., LL.B. (Hons)||Company Sec.||N/A||N/A||1969|
|Ms. Luna Lee||Chief Exec. Officer of Healthsciences International Pte. Ltd.||N/A||N/A||N/A|
New Silkroutes Group Limited, an investment holding company, primarily operates in the healthcare and energy sectors. It operates in Trading of Oil and Gas, and Healthcare segments. The Trading of Oil and Gas segment trades in petrochemical products; generates power; and invests in strategic petrochemical assets. The Healthcare segment owns and operates primary care medical and dental clinics; and provides hospital development and management services. It owns 16 clinics comprising one dental specialist clinic, eight dental clinics, five family medicine clinics, one aesthetic clinic, and one traditional Chinese medicine clinic. This segment also runs employee healthcare benefits programs; offers systems integration services to hospitals and healthcare facilities; distributes dental and medical supplies; and manufactures disposable medical consumables, such as hospital gowns, linen, personal protective equipment, and masks. It also distributes health supplements and Chinese proprietary medicines; provides clinical management and healthscience consultancy services; and offers business, management, and investment consultancy, as well as management services. In addition, the company is involved in the wholesale and retail trading of crude oil, intermediate fuel oil, and other distillates; and chartering of ships. It has operations in Australia, Cambodia, China, India, Singapore, South Korea, Switzerland, the United Arab Emirates, and Vietnam. The company was formerly known as Digiland International Limited and changed its name to New Silkroutes Group Limited in July 2015. New Silkroutes Group Limited was incorporated in 1994 and is based in Singapore.
New Silkroutes Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.